These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10208475)

  • 1. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview.
    Gupta S; Camm AJ
    Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic therapy in coronary heart disease--where do we currently stand?
    Anand V; Gupta S
    Cardiovasc Drugs Ther; 2001; 15(3):209-10. PubMed ID: 11713887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an infective aetiology to atherosclerosis?
    Gupta S; Camm AJ
    Drugs Aging; 1998 Jul; 13(1):1-7. PubMed ID: 9679204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chlamydia pneumoniae and atherosclerosis--the hen, the egg or five feathers?].
    Møller K; Skinhøj P
    Ugeskr Laeger; 1999 Sep; 161(37):5173-4. PubMed ID: 10523951
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
    Ngeh J; Anand V; Gupta S
    Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?
    Camm AJ; Fox KM
    Eur Heart J; 2000 Jul; 21(13):1046-51. PubMed ID: 10843822
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic infection in the etiology of atherosclerosis--the case for Chlamydia pneumoniae.
    Gupta S; Camm AJ
    Clin Cardiol; 1997 Oct; 20(10):829-36. PubMed ID: 9377818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery disease.
    Behbahani R; Verme-Gibboney C; Romanelli AM
    Clin Ther; 1999 Aug; 21(8):1286-300; discussion 1285. PubMed ID: 10485501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chlamydia pneumoniae and atherosclerosis].
    Fortini A; Corti G; Cappelletti C
    Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
    Kalayoglu MV; Libby P; Byrne GI
    JAMA; 2002 Dec; 288(21):2724-31. PubMed ID: 12460096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infection hypothesis for the pathogenesis of atherosclerosis--caused by Chlamydia pneumoniae?].
    Durkalec J; Hasik J
    Przegl Lek; 1999; 56(4):299-301. PubMed ID: 10494168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic infections and coronary heart disease.
    Smith D; Gupta S; Kaski JC
    Int J Clin Pract; 1999 Sep; 53(6):460-6. PubMed ID: 10622075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment.
    Ewald PW; Cochran GM
    J Infect Dis; 2000 Jun; 181 Suppl 3():S394-401. PubMed ID: 10839723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae infection and coronary heart disease. Role of C pneumoniae in pathogenesis of atherosclerosis must be determined.
    Numazaki K; Chiba S
    BMJ; 1997 Dec; 315(7121):1538. PubMed ID: 9420502
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.
    Cook PJ
    J Antimicrob Chemother; 1999 Aug; 44(2):145-8. PubMed ID: 10473220
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse models of Chlamydia pneumoniae infection and atherosclerosis.
    Campbell LA; Kuo Cc
    Am Heart J; 1999 Nov; 138(5 Pt 2):S516-8. PubMed ID: 10539863
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of Chlamydia pneumoniae in the pathogenesis of coronary disease].
    Kähler J; Köster R; Bräser JH; Schäfer P; Terres W; Hamm CW; Meinertz T
    Z Kardiol; 1999 Nov; 88(11):885-95. PubMed ID: 10643056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.